- How to interpret PCT at the bedside in COVID-19 patients?
- Management of COVID-19
- Webinar: Procalcitonin as an Aid for Risk Assessment in COVID-19 (SARS-CoV-2) and Influenza Related Secondary Bacterial Infections
- Educational events in support of Sepsis Awareness Month
- Sepsis Alliance webinar series
How to interpret PCT at the bedside in COVID-19 patients?
Learn more on interpretation of PCT at the bedside in COVID-19 patients from Prof. Zsolt Molnár (University of Pécs, Hungary and Poznan University of Medical Sciences, Poland).
Find out more about PCT as an aid for early risk assessment and prioritization of high risk patients
Management of COVID-19
Medical Chronicle, in partnership with Thermo Fisher Scientific, presents this one hour CPD webinar on the topic of COVID-19 management.
Webinar: Procalcitonin as an Aid for Risk Assessment in COVID-19 (SARS-CoV-2) and Influenza Related Secondary Bacterial Infections
The webinar held on Friday, May 8th at 12-1 PM EDT
Description:
Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections (LRTI) and sepsis.
PCT now also demonstrates evolving evidence as a valuable tool in current COVID-19 epidemics to aid in early identification of patients at low risk of bacterial infection on admission as well as assist in the detection of bacterial co-infection in hospitalized patients.
Join Andrew Meltzer, MD and Mike Broyles, BSPharm, RPh, PD, PharmD as they share the latest information on the role of Procalcitonin (PCT) in the management of these critical patients.
Educational events in support of Sepsis Awareness Month
Sponsored Webinar:
The Blind Spot of Antibiotic Stewardship: Antibiotic Overuse at Discharge
Available on demand
Description:
Appropriate antibiotic use is critical to improve patient outcomes and reduce adverse harm and antibiotic resistance. Half of all antibiotic use related to acute hospitalization for infection occurs after hospital discharge, yet most antibiotic stewardship programs don’t target prescribing at discharge. Thus, while antibiotics when prescribed appropriately can be life-saving, often times antibiotics prescribed at discharge extend beyond duration typically recommended for the infection and are inappropriate or unnecessary. Hosted by the Sepsis Alliance and sponsored by Thermo Fisher Scientific, this webinar will address the current state of antibiotic use at discharge, discuss why providers often overprescribe at discharge, and help improve prescribing and patient outcomes.
Find more free webinars in support of Sepsis Awareness Month, September 2019
Webinars for Healthcare Professionals (Sepsis Alliance)
Webinar series "Sepsis: Across the Continuum of Care"
Supported by our license partner bioMérieux
This webinar series is aimed at addressing sepsis education and subtopics across the entire continuum of care – from critical care nurses to home care staff.
Communicating with Sepsis Patients: A Survivor’s Story
Description:
There are an estimated 1.4 million patients who survive sepsis each year in the United States. Hear firsthand from Darrell Raikes, a sepsis survivor and 2019 Erin Kay Flatley Spirit Award Winner, as he discusses his 32-day ICU stay and ensuing recovery. Participants will learn about post-sepsis physical, cognitive, and emotional challenges faced by many sepsis survivors. A Critical Care specialist will review the importance of early sepsis recognition to improve patient outcomes. There will also be a discussion on communication strategies to ensure that patients and their healthcare team have a mutual understanding of the patient’s condition after sepsis is diagnosed and treated.
Further webinars on the website of our license partner bioMérieux:
